HIF1A and hepatocellular carcinoma: In contrast, UBE2V1 overexpression significantly increased tumor growth, while systemic administration of PX-478 suppressed tumor development in a dose-dependent manner, confirming that the pro-tumorigenic effects of UBE2V1 in HCC are mediated through HIF-1α activation (Fig. 8K to N).